The Prognostic Role and Nomogram Establishment of a Novel Prognostic Score Combining with Fibrinogen and Albumin Levels in Patients with WHO Grade II/III Gliomas

References

• Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(Suppl 4):iv1–iv62. doi:10.1093/neuonc/nov189
   PubMed Web of Science ®Google Scholar
• Walsh KM, Ohgaki H, Wrensch MR. Epidemiology. Handb Clin Neurol. 2016;134:3–18.
   PubMedGoogle Scholar
• Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(Suppl 4):iv1–63. doi:10.1093/neuonc/nou223
   PubMed Web of Science ®Google Scholar
• Abrigo JM, Fountain DM, Provenzale JM, et al. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Cochrane Database Syst Rev. 2018;1:CD011551. doi:10.1002/14651858.CD011551.pub2
   PubMed Web of Science ®Google Scholar
• Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3):215–219. doi:10.1093/jnen/61.3.215
   PubMed Web of Science ®Google Scholar
• Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381–397.
   PubMedGoogle Scholar
• Ding H, Huang Y, Li Z, et al. Prediction of IDH status through MRI features and enlightened reflection on the delineation of target volume in low-grade gliomas. Technol Cancer Res Treat. 2019;18:1533033819877167. doi:10.1177/1533033819877167
   Web of Science ®Google Scholar
• Pouratian N, Schiff D. Management of low-grade glioma. Curr Neurol Neurosci Rep. 2010;10(3):224–231. doi:10.1007/s11910-010-0105-7
   PubMed Web of Science ®Google Scholar
• Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; Group EGW. High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii93–101. doi:10.1093/annonc/mdu050
   PubMed Web of Science ®Google Scholar
• Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028–1030. doi:10.1038/sj.bjc.6601242
   PubMed Web of Science ®Google Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1):302–310. doi:10.1245/s10434-014-3857-5
   PubMed Web of Science ®Google Scholar
• He ZQ, Ke C, Al-Nahari F, et al. Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas. J Neurooncol. 2017;132(2):239–247. doi:10.1007/s11060-016-2361-0
   PubMed Web of Science ®Google Scholar
• Chan DY, Syn NL, Yap R, et al. Conversion surgery post-intraperitoneal paclitaxel and systemic chemotherapy for gastric cancer carcinomatosis peritonei. are we ready? J Gastrointest Surg. 2017;21(3):425–433. doi:10.1007/s11605-016-3336-3
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Qureshi YA, Sarker SJ, Walker RC, Hughes SF. Proximal resection margin in ivor-lewis oesophagectomy for cancer. Ann Surg Oncol. 2017;24(2):569–577. doi:10.1245/s10434-016-5510-y
   PubMed Web of Science ®Google Scholar
• Gan Y, Zhou X, Niu X, et al. Neutrophil/lymphocyte ratio is an independent prognostic factor in elderly patients with high-grade gliomas. World Neurosurg. 2019;127:e261–e267. doi:10.1016/j.wneu.2019.03.085
   PubMed Web of Science ®Google Scholar
• Armocida D, Pesce A, Di Giammarco F, Frati A, Santoro A, Salvati M. Long term survival in patients suffering from glio-blastoma multiforme: a single-center observational cohort study. Diagnostics (Basel). 2019;9(4). doi:10.3390/diagnostics9040209
   PubMedGoogle Scholar
• Dietterle J, Wende T, Wilhelmy F, et al. The prognostic value of peri-operative neurological performance in glioblastoma patients. Acta Neurochir (Wien). 2019;162:417–425. doi:10.1007/s00701-019-04136-4
   PubMed Web of Science ®Google Scholar
• Marques C, Carvelli J, Biard L, et al. Prognostic factors in anti-glomerular basement membrane disease: a multicenter study of 119 patients. Front Immunol. 2019;10:1665. doi:10.3389/fimmu.2019.01665
   PubMed Web of Science ®Google Scholar
• Picca A, Berzero G, Sanson M. Current therapeutic approaches to diffuse grade II and III gliomas. Ther Adv Neurol Disord. 2018;11:1756285617752039. doi:10.1177/1756285617752039
   Web of Science ®Google Scholar
• Seystahl K, Wiestler B, Hundsberger T, et al. Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. Eur Neurol. 2013;69(2):95–101. doi:10.1159/000343811
   PubMed Web of Science ®Google Scholar
• Chen S, Yan H, Du J, et al. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis. Clin Chim Acta. 2018;482:203–208. doi:10.1016/j.cca.2018.04.012
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang W, Que Y, et al. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma. BMC Cancer. 2018;18(1):942. doi:10.1186/s12885-018-4856-x
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen W, Hu C, et al. Albumin and fibrinogen combined prognostic grade predicts prognosis of patients with prostate cancer. J Cancer. 2017;8(19):3992–4001. doi:10.7150/jca.21061
   PubMed Web of Science ®Google Scholar
• Li SQ, Jiang YH, Lin J, et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med. 2018;7(4):1221–1231. doi:10.1002/cam4.1428
   PubMed Web of Science ®Google Scholar
• Ying J, Zhou D, Gu T, Huang J, Liu H. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy. BMC Cancer. 2019;19(1):288. doi:10.1186/s12885-019-5490-y
   PubMed Web of Science ®Google Scholar
• Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci. 2001;936:406–425. doi:10.1111/j.1749-6632.2001.tb03525.x
   PubMed Web of Science ®Google Scholar
• Gulen ST, Karadag F, Karul AB, et al. Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung. 2012;190(3):327–332. doi:10.1007/s00408-011-9364-6
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005;105(1):178–185. doi:10.1182/blood-2004-06-2272
   PubMed Web of Science ®Google Scholar
• Esmon CT. Does inflammation contribute to thrombotic events? Haemostasis. 2000;30(Suppl 2):34–40. doi:10.1159/000054161
   PubMedGoogle Scholar
• Dolan RD, Laird BJA, Klepstad P, et al. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer. Medicine (Baltimore). 2019;98(37):e17019. doi:10.1097/MD.0000000000017019
   PubMed Web of Science ®Google Scholar
• Xu Q, Yan Y, Gu S, et al. A novel inflammation-based prognostic score: the fibrinogen/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res. 2018;2018:4925498. doi:10.1155/2018/4925498
   PubMed Web of Science ®Google Scholar
• Wang PF, Meng Z, Song HW, et al. Preoperative changes in hematological markers and predictors of glioma grade and survival. Front Pharmacol. 2018;9:886. doi:10.3389/fphar.2018.00886
   PubMed Web of Science ®Google Scholar
• Han S, Huang Y, Li Z, Hou H, Wu A. The prognostic role of preoperative serum albumin levels in glioblastoma patients. BMC Cancer. 2015;15:108. doi:10.1186/s12885-015-1125-0
   PubMed Web of Science ®Google Scholar
• Reynes G, Vila V, Martin M, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol. 2011;102(1):35–41. doi:10.1007/s11060-010-0290-x
   PubMed Web of Science ®Google Scholar
• Loeffler S, Fayard B, Weis J, Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer. 2005;115(2):202–213. doi:10.1002/ijc.20871
   PubMed Web of Science ®Google Scholar
• Albrecht U, Yang X, Asselta R, et al. Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell Signal. 2007;19(9):1866–1878. doi:10.1016/j.cellsig.2007.04.007
   PubMed Web of Science ®Google Scholar
• Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. 1988;8(2):385–401. doi:10.1002/hep.1840080234
   PubMed Web of Science ®Google Scholar
• Li SQ, You XH, Sun F, et al. Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy. J Thorac Dis. 2019;11(Suppl 15):S2036–S2038. doi:10.21037/jtd.2019.08.96
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Wang J, Qu J, Li Z, et al. A prognostic model in metastatic or recurrent gastric cancer patients with good performance status who received first-line chemotherapy. Transl Oncol. 2016;9(3):256–261. doi:10.1016/j.tranon.2016.04.004
   PubMed Web of Science ®Google Scholar
• Lee S, Oh SY, Kim SH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. doi:10.1186/1471-2407-13-350
   PubMed Web of Science ®Google Scholar
• Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu C, Dong Z, Da-jian Z. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta-analysis. Int J Surg. 2015;21:84–91. doi:10.1016/j.ijsu.2015.07.681
   PubMed Web of Science ®Google Scholar
• Wang J, Qu J, Li Z, et al. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer. J Clin Lab Anal. 2018;32(1):e22185. doi:10.1002/jcla.22185
   PubMed Web of Science ®Google Scholar
• Wang DP, Kang K, Lin Q, Hai J. Prognostic significance of preoperative systemic cellular inflammatory markers in gliomas: a systematic review and meta-analysis. Clin Transl Sci. 2019;13:179–188. doi:10.1111/cts.12700
   PubMed Web of Science ®Google Scholar
• Yang T, Mao P, Chen X, et al. Inflammatory biomarkers in prognostic analysis for patients with glioma and the establishment of a nomogram. Oncol Lett. 2019;17(2):2516–2522. doi:10.3892/ol.2018.9870
   PubMed Web of Science ®Google Scholar
• Madsen LT. Cancer prediction nomograms for advanced practitioners in oncology. J Adv Pract Oncol. 2014;5(5):380–382.
   PubMedGoogle Scholar
• Giordano A, Egleston BL, Hajage D, et al. Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients. Clin Cancer Res. 2013;19(6):1596–1602. doi:10.1158/1078-0432.CCR-12-3137
   PubMed Web of Science ®Google Scholar